FDA WARNING_LETTER - Buy Keta Online / www.buyketaonline.com - March 02, 2026

On June 23, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to the online entity Buy Keta Online (www.buyketaonline.com) following an investigation into its digital operations on March 2, 2026. The FDA identified significant violations of the Federal Food, Drug, and Cosmetic Act, specifically involving the distribution of unapproved and misbranded ketamine products, including liquid solutions, capsules, and nasal sprays. The primary issues identified involve the sale of prescription-only drugs without medical supervision or a valid prescription from a licensed practitioner. The FDA noted that these products were marketed for serious conditions such as treatment-resistant depression and pain management without the safety and efficacy assurances provided by the formal drug approval process. Additionally, the company failed to meet the legal requirements for drug compounding or registration as an outsourcing facility. The agency expressed particular concern regarding injectable products, which pose severe risks of life-threatening infections when produced outside of regulated oversight. To resolve these violations, the FDA requires Buy Keta Online to immediately cease the sale of these unapproved medications. The company must submit a written response within 15 business days detailing the corrective actions taken to address the violations and the preventative measures implemented to ensure future compliance. Continued failure to comply with federal law may result in legal actions, including product seizures or court-ordered injunctions.